Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women

Circulation
Aruna D PradhanP M Ridker

Abstract

Plasma markers of fibrinolytic function are associated with incident coronary events among several, but not all, prospective epidemiologic investigations of healthy individuals. Few studies have evaluated this relationship in women. In addition, although menopausal hormone therapy (HT) may alter markers of fibrinolytic function, the relevance of this effect for coronary risk assessment has not been studied. In a prospective, nested case-control study among 75 343 postmenopausal women without prior cardiovascular disease or cancer, we evaluated the relationships of elevated tissue plasminogen activator (tPA) antigen and D-dimer with subsequent first coronary heart disease events over a median period of 2.9 years. Baseline levels of both biomarkers were higher among 304 cases compared with 304 controls matched on age, smoking status, ethnicity, and length of follow-up; median values were 9.0 versus 7.4 ng/mL (P<0.001) for tPA antigen and 27.6 versus 23.4 ng/mL (P=0.001) for D-dimer. In matched-pairs analyses, the odds ratio in the highest versus lowest quartile of tPA antigen was 3.5 (95% CI, 2.1 to 5.8; P trend <0.001) and for D-dimer was 2.0 (95% CI, 1.2 to 3.2; P trend=0.005). After adjustment for lipid and nonlipid risk facto...Continue Reading

References

May 1, 1992·The American Journal of Medicine·E J Eichhorn
Jan 30, 1992·The New England Journal of Medicine·V FusterJ H Chesebro
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Feb 10, 1989·JAMA : the Journal of the American Medical Association·L W Stevenson, J K Perloff
Mar 27, 1993·Lancet·J Lob-levyt
Aug 15, 1996·The New England Journal of Medicine·J N Cohn
Feb 6, 1997·The New England Journal of Medicine·P J Hauptman, K J O'Connor
Feb 20, 1997·The New England Journal of Medicine·UNKNOWN Digitalis Investigation Group
Mar 6, 1997·The New England Journal of Medicine·K K KohR O Cannon
Aug 15, 1997·Developmental Biology·D J GarryR S Williams
Sep 23, 1997·The American Journal of the Medical Sciences·R P Frantz, L J Olson
Dec 31, 1997·The New England Journal of Medicine·UNKNOWN Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators
Jun 12, 1998·The New England Journal of Medicine·J A Fishman, R H Rubin
Nov 20, 1998·The New England Journal of Medicine·D J GoldsteinE A Rose
Dec 1, 1998·Scandinavian Journal of Clinical and Laboratory Investigation·A Nordenhem, B Wiman
Feb 19, 1999·Lancet

❮ Previous
Next ❯

Citations

Apr 9, 2009·Nature Reviews. Cardiology·Joseph M SweenyValentin Fuster
Nov 3, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A P B BatschauerM G Carvalho
Sep 1, 2006·Current Opinion in Critical Care·Natalie Khuseyinova, Wolfgang Koenig
Jun 3, 2009·Journal of Cardiovascular Pharmacology·Yoshinao SugaiHiroaki Shimokawa
Sep 20, 2011·Menopause : the Journal of the North American Menopause Society·Rebecca C ThurstonKaren A Matthews
Apr 20, 2011·Circulation·Nicholas L SmithCaroline Hayward
Jan 8, 2009·The Journal of Clinical Endocrinology and Metabolism·Christine G LeeJohn D Brunzell
Jul 29, 2009·Journal of Endocrinological Investigation·S YenerS Yesil
Dec 15, 2010·International Journal of Vascular Medicine·V P DiegoJ Blangero
Dec 4, 2008·Thrombosis Research·Ana PortelinhaIrene Rebelo
Apr 16, 2008·Thrombosis Research·A TrifilettiN Frisina
Aug 20, 2011·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Eftihia SbarouniVassilis Voudris
Apr 25, 2015·Journal of the American College of Cardiology·Osita N Okafor, Diana A Gorog
Jun 12, 2010·Journal of the American College of Cardiology·Diana A Gorog
Apr 15, 2006·Arteriosclerosis, Thrombosis, and Vascular Biology·Sekar KathiresanChristopher J O'Donnell
Nov 26, 2004·American Journal of Physiology. Heart and Circulatory Physiology·Mark D IafratiJane E Freedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.